account_balance

Investment manager · 13F filer · SEC CIK 1442756

PFM Health Sciences, LP

Reported value$1.15Bas of Jun 30, 2026
Positions96 33 new, 14 sold out
Top 10 weight34.3%ASND alone is 5%
FiledAug 1445 days after quarter end

Portfolio · as of Jun 30, 2026

Where the money is

New or addedTrimmedHeld

Boxes show the top 12 stocks, sized against each other. The bar above shows how much of the fund they are. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.

Show the top 12 as a list

What changed

Biggest moves since Mar 31, 2026

Filed Aug 14, 2026, compared with the May 15, 2026 filing
add_circleNew
arrow_upwardAdded
arrow_downwardTrimmed
remove_circleSold out
  • Ascendis Pharma A/s $34.8M
  • GKOS $23.2M
  • Centessa Pharmaceuticals PLC $21M
  • Ascendis Pharma A/s $16.9M

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate.

This is data, not investment advice. About StockToast